findmyKOL

Anwar Tandar, MD

Enriched profile

Professor of Medicine, Division of Cardiology; Co-Director of the Valve Clinic Program and TAVR Program · University of Utah

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Salt Lake City, UT · West · United StatesSpecialtyInterventional CardiologyFocusCardiac Valve Diseases and Treatments+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Anwar Tandar is Professor of Medicine, Division of Cardiology; Co-Director of the Valve Clinic Program and TAVR Program at University of Utah. OpenAlex indexes 88 publications with 1,033 citations (h-index 15); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 17 Oct 2026

Overview

Updated 18 Oct 2026

Anwar Tandar, MD, is Professor of Medicine, Division of Cardiology at University of Utah. The public record shows 88 publications with 1,033 citations (h-index 15), centered on Cardiac Valve Diseases and Treatments, Coronary Interventions and Diagnostics, Mechanical Circulatory Support Devices. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 12 companies.

  • Most recent indexed publication: 2026 · Stroke
  • Top research focus: Cardiac Valve Diseases and Treatments
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 12 companies

Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Stroke1 trialForamen Ovale, Patent1 trialCoronary Artery Disease / ACS

Research focus

OpenAlex concept fingerprint
Cardiac Valve Diseases and TreatmentsCoronary Interventions and DiagnosticsMechanical Circulatory Support DevicesAortic Disease and Treatment ApproachesAcute Myocardial Infarction Research

Works with

trial sponsors and companies reporting payments
Edwards Lifesciences CorporationClinical trials—Industry payments99W. L. Gore & Associates, Inc.Clinical trials—Industry payments38Boston Scientific CorporationClinical trials—Industry payments27Abbott LaboratoriesClinical trials—Industry payments12Philips North America LLCClinical trials—Industry payments6ShockWave Medical, IncClinical trials—Industry payments5AbiomedClinical trials—Industry payments3Merit Medical Systems IncClinical trials—Industry payments3Medtronic, Inc.Clinical trials—Industry payments2Recor Medical IncClinical trials—Industry payments1University of UtahClinical trials1Industry payments—W.L.Gore & AssociatesClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
88publications

Distinct works indexed by OpenAlex, matched via ORCID; 3 in PubMed.

1,033citations

Total citations across indexed works.

15h-index

Hirsch index (OpenAlex). i10-index 18.

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
12companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 18 Oct 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 18 Oct 2026

12 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    70.4%
    Beta blocker29.6%
    Metoprolol Succinate49%Metoprolol Tartrate25%Carvedilol25%
    Part D<11 patients
    Statin18.3%
    Atorvastatin Calcium55%Rosuvastatin Calcium46%
    Part D<11 patients

    + 4 more classes in this area

  • Metabolism & gastrointestinal

    13.8%
    SGLT2 inhibitor13.8%
    Jardiance100%
    Part D<11 patients
  • Blood & clotting

    10.4%
    P2Y12 inhibitor5.8%
    Clopidogrel100%
    Part D<11 patients
    Factor Xa inhibitor4.6%
    Eliquis100%
    Part D<11 patients
All 4 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)88.8% facility · 11.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 18 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 18 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Frederick G.P. Welt28Stavros George Drakos13Craig H. Selzman12Jason P. Glotzbach11Vikas Sharma10Elizabeth Dranow10Josef Stehlik10Omar Wever‐Pinzon9Stephen H. McKellar9Joseph E. Tonna8Edward Michael Gilbert8Antigone G. Koliopoulou8Iosif Taleb8Jose N. Nativi-Nicolau8Theophilus Owan8David A. Bull8Abdulfattah Saidi7Koohyar Vahidkhah6Rodney S. Badger6Ali N. Azadani6Peyman Nejatbakhsh Azadani6Tara L. Jones6Mostafa Abbasi6Shahnaz Javani5James Chen-Tson Fang5Danny Dvir5Jack H. Morshedzadeh5Anu Abraham5James C. Fang5Homam Ibrahim4Joseph Boone Muhlestein4Jonathan M. Tobis4Heidi Thomas May4Joseph Brent Muhlestein4William E. Boden4Amit N. Patel4Brian K. Whisenant4Jeffrey L. Anderson4Andrew D. Michaels4Byung-Soo Ko4

Online presence

Updated 18 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/anwar-tandar-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 18 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Sriwijaya University, Indonesia

    1994
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthcare.utah.edu ↗
  • Board certified

    American Board of Internal Medicine: Cardiovascular Disease and Interventional Cardiology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthcare.utah.edu ↗

Editorial & leadership roles

journal and society appointments
  • Fellow

    American College of Cardiology (FACC)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthcare.utah.edu ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.